12.450
+0,00%
2026-10-16
Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +44.9% | +28.2% | 2 / 3 | +13.9% | +0.32 pp | +2.02 pp | +6.1% | 0.00 | 8.18 | 80,4 | +13,9% | 8,0 | +43,0% | 8.18 | 12.72 | −35,7% |
| Pts | 8 | 4 | 8 | 4 | 8 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 12.450 (close price on 2026-10-16)EPS (TTM): 1.522
Financial charts
1.Revenue & growth
VND bn80,4Q2/26
1.Revenue & growth
VND bn80,4Q2/26
2.Profit & growth
VND bn7,88Q2/26
3.Profit mix (Penman)
VND bn26,4Q2/26
4.Margins & cost structure
%16.0%Q2/26
5.Returns & cash cycle
% · days12.7%Q2/26
6.Earnings quality & cash
VND bn10,5Q2/26
7.Asset structure
VND bn402Q2/26
8.Funding & debt health
VND bn · times402Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %8,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %602Q2/26
Adjusted EPS growth, latest quarter
44.9%
Average adjusted EPS growth, 3 quarters
28.2%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26